Armata Pharmaceuticals ARMP
NYSE ARMP
$5.10 +0.68 (+15.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

Armata Pharmaceuticals (ARMP) Net Equity Issued and Repurchased (2016 - 2022)

Armata Pharmaceuticals (ARMP) posted Net Equity Issued and Repurchased of -$23000.0 for Q3 2022, up 89.4% sequentially from -$217000.0 in Q2 2022.

Armata Pharmaceuticals (ARMP) Net Equity Issued and Repurchased (2016 - 2022) Analysis & Trends

Armata Pharmaceuticals has reported Net Equity Issued and Repurchased for 4 years, with the latest figure at -$23000.0 in Q3 2022.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to -$23000.0 in Q3 2022, while the trailing twelve-month figure through Dec 2022 was $44.4 million (up 68.67% YoY) and the FY2022 annual result came in at $44.4 million, up 68.67% from the prior year.
  • Net Equity Issued and Repurchased rose to -$23000.0 in Q3 2022 per ARMP's latest filing, from -$217000.0 in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $44.6 million in Q1 2022 and troughed at -$412000.0 in Q2 2020.
  • A 3-year average of $10.4 million and a median of -$23000.0 in 2022 frame the typical range for Net Equity Issued and Repurchased.
  • The widest YoY moves for Net Equity Issued and Repurchased: up 128.31% in 2022, down 17.3% in 2022.
  • Over 3 years, Net Equity Issued and Repurchased stood at -$26000.0 in 2020, then soared by 26853.85% to $7.0 million in 2021, then tumbled by 100.33% to -$23000.0 in 2022.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered -$23000.0, -$217000.0, and $44.6 million for Q3 2022, Q2 2022, and Q1 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Armata Pharmaceuticals 182.82 Mn 158.82 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 -23,000.00
Sep 30, 2022 -23,000.00
Jun 30, 2022 -217,000.00
Jun 30, 2022 -217,000.00
Mar 31, 2022 44.63 Mn
Mar 31, 2022 44.63 Mn
Dec 31, 2021 6.96 Mn
Dec 31, 2021 6.96 Mn
Jun 30, 2021 -185,000.00
Jun 30, 2021 -185,000.00
Mar 31, 2021 19.55 Mn
Mar 31, 2021 19.55 Mn
Sep 30, 2020 -26,000.00
Sep 30, 2020 -26,000.00
Jun 30, 2020 -412,000.00
Jun 30, 2020 -412,000.00
Mar 31, 2020 23.33 Mn
Mar 31, 2020 23.33 Mn
Dec 31, 2016 3.34 Mn
Dec 31, 2016 3.34 Mn